2026 NPPES data Pulmonary Disease Physician NPI 1336245109 MD
Verify on CMS →

NICHOLAS MAGLARAS, MD

Pulmonary Disease Physician in ROSELLE PARK, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 447 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
75%
generic claims · 25% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
22.8638/100
▼ 60 pts below national avg 83.1 · [object Object]
Industry payments
$59.75
4 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NICHOLAS MAGLARAS, MD reported a CMS MIPS final score of 22.8638/100 — below the 83.1 national average — and filed 4,214 Medicare Part D claims in 2023.

22.8638/100
MIPS score · -60 vs avg
4K
Part D claims, 2023
75%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NICHOLAS MAGLARAS, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

23 3rd percentile higher than 3% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). This entry sits in this band. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NICHOLAS MAGLARAS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NICHOLAS MAGLARAS, MD?

Below national average

NPI registry status

Active

Issued 09/16/2006

NPI 1336245109

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

4,214 189% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

MIPS final score

22.8638/100 60.2362% pts

Below average band

vs 83.1 national avg

Specialty distribution in New Jersey

How Pulmonary Disease Physician compares to other specialties among New Jersey providers

New Jersey providers

Pulmonary Disease Physician share within New Jersey

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within New Jersey

Medicare quality performance — MIPS

NICHOLAS MAGLARAS, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average

Below national average
MIPS Final Score
22.8638/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pulmonary Disease Physician) — 22.8638/100 vs national avg 83.1

0%100%National avg83%22.9%
MIPS final score (Pulmonary Disease Physician) — 22.8638/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NICHOLAS MAGLARAS, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 236 E WESTFIELD AVE, ROSELLE PARK, NJ, 07204, with a listed phone of (908) 245-8222. NPI 1336245109 was issued on 09/16/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MAGLARAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,214 prescription claims written by this provider, covering 447 Medicare beneficiaries and totaling roughly $741K in drug spend, split 25% brand-name and 75% generic by claim count, with an opioid prescribing rate of 0.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 22.8638/100 for the 2023 performance year (Quality 15, Cost 46.316), compared with the national average of 83.1.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

236 E WESTFIELD AVE
ROSELLE PARK, NJ 07204

Provider Details

NPI 1336245109
Specialty Pulmonary Disease Physician
Credentials MD
Gender Male
NPI Issued 09/16/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

22.8638
Final Score
Avg: 83.1
15
Quality
46.316
Cost

Reporting: Individual

Hospital and facility affiliations

Facilities where NICHOLAS MAGLARAS, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NICHOLAS C MAGLARAS MD LLP
ROSELLE PARK, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NICHOLAS MAGLARAS, MD. Source: openpaymentsdata.cms.gov.

Total received

$60

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

NICHOLAS MAGLARAS, MD — brand share 25.0%
Specialty average (est.)

25% brand-name claims vs 75% generic, on 4,214 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,214
Total Claims
$741K
Total Drug Cost
447
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,551
Total Day Supply
206,802
Brand vs Generic
25% brand / 75% generic
Brand Drug Cost
$619K
Generic Drug Cost
$121K
Opioid Claims
33 (0.8% rate)
Antibiotic Claims
129

Patient Demographics

Average Patient Age
80.3 years
Avg HCC Risk Score
1.46
Gender Split
63% female / 37% male
Age Distribution
<65: 14, 65-74: 111, 75-84: 168, 85+: 154

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NICHOLAS MAGLARAS, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
361
Amlodipine Besylate
212
Simvastatin
185
Levothyroxine Sodium
171
Atorvastatin Calcium
144
Metoprolol Succinate
119
Prednisone
111
Albuterol Sulfate Hfa
Albuterol Sulfate
110
Furosemide
91
Losartan Potassium
84

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How NICHOLAS MAGLARAS, MD fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

NICHOLAS MAGLARAS, MD's 4,214 claims are above the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as MAGLARAS.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NICHOLAS MAGLARAS, MD's specialty?
NICHOLAS MAGLARAS, MD specializes in Pulmonary Disease Physician and practices in ROSELLE PARK, New Jersey. Credentials: MD.
How much does NICHOLAS MAGLARAS, MD prescribe under Medicare Part D?
In 2023, NICHOLAS MAGLARAS, MD wrote 4,214 Medicare Part D claims totaling $741K in drug costs for 447 beneficiaries.
What is NICHOLAS MAGLARAS, MD's Medicare quality score?
NICHOLAS MAGLARAS, MD has a CMS MIPS Final Score of 22.8638/100 (Quality: 15, Cost: 46.316). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NICHOLAS MAGLARAS, MD located?
NICHOLAS MAGLARAS, MD is located at 236 E WESTFIELD AVE, ROSELLE PARK, NJ, 07204. Phone: (908) 245-8222.
What is NICHOLAS MAGLARAS, MD's NPI number?
NICHOLAS MAGLARAS, MD's National Provider Identifier (NPI) is 1336245109, issued on 09/16/2006.
Does NICHOLAS MAGLARAS, MD prescribe more brand-name or generic drugs?
NICHOLAS MAGLARAS, MD's prescribing is 25% brand-name and 75% generic drugs by claim count, with $619K in brand drug costs.
Does NICHOLAS MAGLARAS, MD prescribe opioids?
Yes, NICHOLAS MAGLARAS, MD had 33 opioid claims in 2023 with an opioid prescribing rate of 0.8%.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does NICHOLAS MAGLARAS, MD prescribe most often?
Based on 2023 Medicare Part D data, NICHOLAS MAGLARAS, MD's most frequently prescribed drugs include Trelegy Ellipta, Amlodipine Besylate, Simvastatin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NICHOLAS MAGLARAS, MD accept Medicare?
NICHOLAS MAGLARAS, MD appears in CMS Medicare data with 4,214 Part D claims and 447 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NICHOLAS MAGLARAS, MD's credentials?
NICHOLAS MAGLARAS, MD's NPI is 1336245109 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology